TCIM
EW icon

TIAA CREF Investment Management’s Edwards Lifesciences EW Stock Holding History

TIAA CREF Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$555M Sell
8,707,326
-1,179,867
-12% -$67.3M 0.39% 50
2018
Q4 		$505M Sell
9,887,193
-4,515
-0% -$228K 0.4% 52
2018
Q3 		$574M Sell
9,891,708
-54,045
-0.5% -$2.64M 0.37% 56
2018
Q2 		$483M Buy
9,945,753
+2,325,366
+31% +$109M 0.32% 63
2018
Q1 		$354M Buy
7,620,387
+3,826,386
+101% +$166M 0.24% 92
2017
Q4 		$143M Sell
3,794,001
-124,599
-3% -$4.57M 0.09% 222
2017
Q3 		$143M Sell
3,918,600
-801,393
-17% -$30.6M 0.1% 215
2017
Q2 		$186M Sell
4,719,993
-431,688
-8% -$15.8M 0.13% 167
2017
Q1 		$162M Buy
5,151,681
+1,257,798
+32% +$39.4M 0.12% 186
2016
Q4 		$122M Sell
3,893,883
-872,727
-18% -$28.3M 0.09% 238
2016
Q3 		$192M Sell
4,766,610
-514,986
-10% -$19.4M 0.12% 170
2016
Q2 		$176M Buy
5,281,596
+126,153
+2% +$4.32M 0.13% 159
2016
Q1 		$152M Sell
5,155,443
-315,135
-6% -$8.7M 0.12% 178
2015
Q4 		$144M Buy
5,470,578
+272,574
+5% +$7.08M 0.11% 199
2015
Q3 		$123M Buy
5,198,004
+620,856
+14% +$15M 0.1% 225
2015
Q2 		$109M Sell
4,577,148
-16,170
-0.4% -$365K 0.08% 270
2015
Q1 		$109M Buy
4,593,318
+258,672
+6% +$5.8M 0.08% 292
2014
Q4 		$92M Buy
4,334,646
+538,260
+14% +$10.8M 0.06% 323
2014
Q3 		$64.6M Buy
3,796,386
+613,692
+19% +$9.69M 0.05% 412
2014
Q2 		$45.5M Buy
3,182,694
+636,996
+25% +$8.64M 0.03% 504
2014
Q1 		$31.5M Sell
2,545,698
-1,897,866
-43% -$21.9M 0.02% 628
2013
Q4 		$48.7M Sell
4,443,564
-2,548,440
-36% -$28.7M 0.03% 500
2013
Q3 		$81.1M Sell
6,992,004
-2,919,102
-29% -$34.2M 0.06% 321
2013
Q2 		$111M Buy
+9,911,106
New +$117M 0.09% 243

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

TIAA CREF Investment Management's EW Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Edwards Lifesciences (EW) stake by 12% in Q1 2019, selling an estimated $67.3M and leaving 8,707,326 shares worth $555M. The position accounts for 0.39% of the portfolio, ranked #50.

TIAA CREF Investment Management first reported a position in EW in Q2 2013 and has held it in 24 quarters since. The position peaked at $574M in Q3 2018. 923 funds tracked by Wall St. Rank hold EW as of Q1 2019.

  • TIAA CREF Investment Management held 8,707,326 shares of Edwards Lifesciences worth $555M as of Q1 2019.
  • TIAA CREF Investment Management sold 1,179,867 Edwards Lifesciences shares in Q1 2019, an estimated $67.3M.
  • Edwards Lifesciences made up 0.39% of TIAA CREF Investment Management's portfolio in Q1 2019, its #50 holding.
  • TIAA CREF Investment Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Edwards Lifesciences position peaked at $574M in Q3 2018.
  • 923 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.